cas 824423-23-6|| where to buy 1-(3-Acetylphenyl)-3-(7-morpholinobenzo[c][1,2,5]oxadiazol-4-yl)urea

Nom du produit:1-(3-Acetylphenyl)-3-(7-morpholinobenzo[c][1,2,5]oxadiazol-4-yl)urea

IUPAC Name:1-(3-acetylphenyl)-3-[7-(morpholin-4-yl)-2,1,3-benzoxadiazol-4-yl]urea

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 824423-23-6 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:824423-23-6; Formule moléculaire:C19H19N5O4; Point de fusion:-; Code SMILES:O=C(NC1=CC=C(N2CCOCC2)C3=NON=C31)NC4=CC=CC(C(C)=O)=C4; Densité:

: Numéro de catalogue:CM304704; Poids moléculaire:381.39; Point d'ébullition:; N° Mdl:; Stockage:Store at 2-8°C.

: Morpholines; Morpholine contains secondary amine groups and has all the typical reactive characteristics of secondary amine groups. It can react with inorganic acids to form salts, and react with organic acids to form salts or amides, which can be subjected to alkylation reaction, and can also be reacted with ethylene oxide, ketone or Willgerodt reaction. Morpholine is a six-membered ring containing oxygen and nitrogen, and its alkalinity is much lower than that of its parent piperidine. The marketed morpholine drugs are mainly distributed in the fields of tumors, cardiovascular and cerebrovascular diseases, respiratory system diseases, digestive system diseases, infectious diseases and mental disorders.; morpholine price; if you are interested in morpholine price, please feel free to contact us. More information of our products will be forwarded to you upon receipt of your specific inquiry.

: Benzofurazans; Benzofurazans are important pharmaceutical intermediates. Benzofurazans are known bioisosteres of the nitro group. Both oxadiazoles and nitro groups have strong electron-withdrawing properties, but when optimizing drug-like properties such as activity, selectivity, and stability, the absence of standard charges in the oxadiazole structure may be more beneficial to drug products. What's more, nitro groups have been identified as toxic groups, and it is routine to remove or replace them in the early stages of drug development.